{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:07:06Z","timestamp":1767848826036,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,3]]},"DOI":"10.7759\/cureus.66057","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T09:07:41Z","timestamp":1722676061000},"source":"Crossref","is-referenced-by-count":5,"title":["Tracking KP.2 SARS-CoV-2 Variant in India and the Clinical Profile of KP.2 Cases in Maharashtra, India"],"prefix":"10.7759","author":[{"given":"Rajesh P","family":"Karyakarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmita","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhakti","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Joy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyani","family":"Jagarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damini","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Chamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanathan","family":"DV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyabom","family":"Taji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Gurav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvarna","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2358383","article-title":"Another variant another history: Description of the SARS-CoV-2\u2009KP.2 (JN.1.11.1.2) mutations","volume":"56","author":"Branda F","year":"2024","unstructured":"Branda F, Ciccozzi A, Romano C, Ciccozzi M, Scarpa F. Another variant another history: Description of the SARS-CoV-2\u2009KP.2 (JN.1.11.1.2) mutations. Infect Dis (Lond). 2024, 56:581-5. 10.1080\/23744235.2024.2358383","journal-title":"Infect Dis (Lond)"},{"key":"ref2","unstructured":"Initial risk evaluation of BA.2.86 and its sublineages. (2023). Accessed. July 1, 2024: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/21112023_ba.2.86_ire.pdf?sfvrsn=8876def1_3."},{"key":"ref3","unstructured":"COVID-19 epidemiological update - 19 January 2024. edition 163. (2024). Accessed: July 1, 2024: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---19-january-2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.20.595020","article-title":"Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion","author":"Li P","year":"2024","unstructured":"Li P, Faraone JN, Hsu CC, et al.. Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion. bioRxiv. 2024, 10.1101\/2024.05.20.595020","journal-title":"bioRxiv"},{"key":"ref5","unstructured":"Tracking SARS-CoV-2 variants. World Health Organization. (2024). Accessed. July 1, 2024: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants."},{"key":"ref6","unstructured":"COVID-19 Epidemiological Update - 17 June 2024. edition 168. World Health Organization. (2024). Accessed: July 1, 2024: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-168."},{"key":"ref7","unstructured":"Indian Biological Data Centre (IBDC). Accessed. June 24, 2024: https:\/\/ibdc.rcb.res.in\/."},{"key":"ref8","unstructured":"Wastewater Surveillance Dashboard for Infectious Diseases (COVID-19, H1N1, H3N2, Influenza-A) - The Pune Knowledge Cluster (PKC). (2021). Accessed. July 6, 2024: https:\/\/www.pkc.org.in\/pkc-focus-area\/health\/waste-water-surveillance\/wws-covid-dashboard-pune\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00298-6","article-title":"Virological characteristics of the SARS-CoV-2 KP.2 variant","volume":"24","author":"Kaku Y","year":"2024","unstructured":"Kaku Y, Uriu K, Kosugi Y, et al.. Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infectious Diseases. 2024, 24:e416. 10.1016\/s1473-3099(24)00298-6","journal-title":"Lancet Infectious Diseases"},{"key":"ref10","unstructured":"covSPECTRUM. KP.2* (Nextclade) World. (2023). Accessed. July 1, 2024: https:\/\/cov-spectrum.org\/explore\/World\/AllSamples\/from%3D2023-12-01%26to%3D2024-06-22\/variants?nextcladePangoLineage=...."},{"key":"ref11","unstructured":"covSPECTRUM. KP.2* (Nextclade) India. (2023). Accessed. July 1, 2024: https:\/\/cov-spectrum.org\/explore\/India\/AllSamples\/from%3D2023-12-01%26to%3D2024-06-22\/variants?nextcladePangoLineage=...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku Y","year":"2024","unstructured":"Kaku Y, Yo MS, Tolentino JE, et al.. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants. Lancet Infect Dis. 2024, 24:E482-3. 10.1016\/s1473-3099(24)00415-8","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.29.596362","article-title":"Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages","author":"Wang Q","year":"2024","unstructured":"Wang Q, Mellis IA, Bowen A, et al.. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages. bioRxiv (Cold Spring Harbor Laboratory). 2024, 10.1101\/2024.05.29.596362","journal-title":"bioRxiv (Cold Spring Harbor Laboratory)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275948-tracking-kp2-sars-cov-2-variant-in-india-and-the-clinical-profile-of-kp2-cases-in-maharashtra-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T09:07:48Z","timestamp":1722676068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275948-tracking-kp2-sars-cov-2-variant-in-india-and-the-clinical-profile-of-kp2-cases-in-maharashtra-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.66057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,3]]}}}